For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Alignment Healthcare Inc (NASDAQ: ALHC) closed at $14.64 in the last session, up 0.21% from day before closing price of $14.61. In other words, the price has increased by $0.21 from its previous closing price. On the day, 1.76 million shares were traded. ALHC stock price reached its highest trading level at $14.75 during the session, while it also had its lowest trading level at $14.48.
Ratios:
We take a closer look at ALHC’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 2.34 whereas as Long-Term Debt/Eq ratio is at 2.34.
On December 03, 2024, Stephens Upgraded its rating to Overweight which previously was Equal-Weight and also upped its target price recommendation from $13 to $17.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 11 ’25 when HYONG J KIM bought 18,600 shares for $14.51 per share.
JOYCE CHRISTOPHER J sold 15,491 shares of ALHC for $247,950 on Jul 31 ’25. The Chief Legal and Admin. Officer now owns 374,531 shares after completing the transaction at $16.01 per share. On Jul 31 ’25, another insider, KONOWIECKI JOSEPH S, who serves as the Director of the company, sold 25,000 shares for $16.00 each. As a result, the insider received 400,000 and left with 1,152,049 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2899174144 and an Enterprise Value of 2725059072. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.87 while its Price-to-Book (P/B) ratio in mrq is 20.56. Its current Enterprise Value per Revenue stands at 0.817 whereas that against EBITDA is 346.435.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.17, which has changed by 0.68858135 over the last 52 weeks, in comparison to a change of 0.18157876 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $8.17. The 50-Day Moving Average of the stock is 6.27%, while the 200-Day Moving Average is calculated to be 2.35%.
Shares Statistics:
According to the various share statistics, ALHC traded on average about 3.41M shares per day over the past 3-months and 4763620 shares per day over the past 10 days. A total of 197.96M shares are outstanding, with a floating share count of 131.46M. Insiders hold about 33.62% of the company’s shares, while institutions hold 66.37% stake in the company. Shares short for ALHC as of 1753920000 were 13476373 with a Short Ratio of 3.95, compared to 1751241600 on 12618961. Therefore, it implies a Short% of Shares Outstanding of 13476373 and a Short% of Float of 10.479999.
Earnings Estimates
The stock of Alignment Healthcare Inc (ALHC) is currently drawing attention from 4.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.
Analysts are recommending an EPS of between $0.18 and $0.14 for the fiscal current year, implying an average EPS of $0.16. EPS for the following year is $0.3, with 4.0 analysts recommending between $0.4 and $0.17.
Revenue Estimates
According to 10 analysts, the current quarter’s revenue is expected to be $978.55M. It ranges from a high estimate of $983.6M to a low estimate of $959M. As of the current estimate, Alignment Healthcare Inc’s year-ago sales were $692.43MFor the next quarter, 10 analysts are estimating revenue of $977.39M. There is a high estimate of $984.01M for the next quarter, whereas the lowest estimate is $968M.
A total of 10 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $3.91B, while the lowest revenue estimate was $3.8B, resulting in an average revenue estimate of $3.89B. In the same quarter a year ago, actual revenue was $2.7BBased on 9 analysts’ estimates, the company’s revenue will be $4.96B in the next fiscal year. The high estimate is $5.47B and the low estimate is $4.77B.
